Zoe Smith

Experimental Biologist at CoSyne Therapeutics

Zoe Smith is a scientist with extensive experience in the fields of functional genomics, mechanistic pharmacology, and drug discovery. Currently part of the Functional Genomics team at CoSyne Therapeutics, Zoe previously worked as a cell scientist at Cancer Research Horizons, focusing on developing spheroid viability assays for cancer research. Previous roles included positions at Cancer Research UK and Sygnature Discovery, where Zoe contributed to integrated drug discovery programs targeting cancer immunotherapy. Zoe holds a PhD in Neuroscience from the University of Nottingham, where research centered on the influence of the extracellular environment on astrocyte phenotype, and a Bachelor's degree in Biology from the University of York. Skills include independently designing experiments, analyzing data, and managing various cell lines, complemented by a strong publication record.

Location

Haverhill, United Kingdom

Links


Org chart

No direct reports

Teams


Offices


CoSyne Therapeutics

CoSyne Therapeutics is a vertically integrated AI Drug Discovery company aiming to bring speed to precision medicine through polymathic AI to help patients with under-served diseases of the brain.


Industries

Employees

11-50

Links